SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

USPTO Issues Notice of Allowance for IRLAB Therapeutics’ IRL1117 Patent

IRLAB Therapeutics said the patent grant remains pending administrative formalities, with protection expected into the early 2040s.

IRLABA

Related stories